Profilo
Martin P.
Redmon is currently the Chief Research & Development Officer at Stealth BioTherapeutics Corp.
He previously held the position of Senior Vice President-Research & Development at PreCision Dermatology, Inc. and Chief Research & Development Officer at Stealth BioTherapeutics, Inc. Dr. Redmon obtained undergraduate and doctorate degrees from the University of Kentucky.
Posizioni attive di Martin Redmon
| Società | Posizione | Inizio |
|---|---|---|
| STEALTH BIOTHERAPEUTICS CORP | Direttore Tecnico/Scientifico/R&S | 16/03/2021 |
Precedenti posizioni note di Martin Redmon
| Società | Posizione | Fine |
|---|---|---|
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Direttore Tecnico/Scientifico/R&S | - |
PreCision Dermatology, Inc.
PreCision Dermatology, Inc. Pharmaceuticals: MajorHealth Technology Develops skincare therapies | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Martin Redmon
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
PreCision Dermatology, Inc.
PreCision Dermatology, Inc. Pharmaceuticals: MajorHealth Technology Develops skincare therapies | Health Technology |
University of Kentucky
University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stealth BioTherapeutics Corp.
Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops investigational drugs for the treatment of diseases involving mitochondrial dysfunction | Health Technology |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Health Technology |
















